Home / inflammatory bowel disease
Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.
J Pediatr Gastroenterol Nutr. 2009 Jan;48(1):55-60.
Wong AP, Clark AL, Garnett EA, Acree M, Cohen SA, Ferry GD, Heyman MB.
Department of Pediatrics and Medicine, University of California, San Francisco, CA 94143-0136, USA.
OBJECTIVES: We examined the use of complementary and alternative medicine (CAM) at 3 US pediatric medical centers, comparing a group of children with inflammatory bowel disease (IBD) with children presenting with chronic constipation.
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Cochrane Database Syst Rev. 2007; (4):CD003960 (ISSN: 1469-493X)
Evans BW; Clark WK; Moore DJ; Whorwell PJ
University of Hertfordshire, School of Pharmacy, College Lane Campus, Hatfield, UK, AL10 9AB. b.w.evans@herts.ac.uk
BACKGROUND: IBS is a complex disorder that encompasses a wide profile of symptoms. The symptoms of chronic constipation frequently resemble those of constipation-predominant IBS. Current drug treatments for irritable bowel syndrome (IBS) are of limited value. Many target specific symptoms only. Tegaserod, a 5HT(4) partial agonist, represents a novel mechanism of action in the treatment of IBS and chronic constipation.
